logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
S

Satoshi Morita

kyoto university

85H指数
1.3K论文数
4.0W被引数
收录论文 375
发表时间
logo
Retinal Arterial Wall Reflectivity and Incident Cardiovascular Disease视网膜动脉壁反射性与心血管疾病发病率
errOphthalmology Science
IF4.6
err2026-09-04
err0
errOAAI
errRan Xiang; Yuki Muraoka; Takahiro Kogo; Yu Hidaka; Yuki Mori; Masayuki Hata; Masahiro Miyake; Satoshi Morita; Takahiro Horie; Koh Ono; Yasuharu Tabara; Fumihiko Matsuda; Akitaka Tsujikawa
err分享
err收藏
Clinical value of prostate-specific antigen halving time as a predictor of response to first-line systemic treatment for synchronous metastatic castration-sensitive prostate cancer前列腺特异性抗原半衰期作为同步转移性去势敏感前列腺癌一线系统性治疗效果预测指标的临床价值
errInternational Journal of Clinical Oncology
IF2.8
err2026-08-25
err0
PREAI
errTakanari Kambe; Takayuki Sumiyoshi; Hiroshi Fujiwara; Takeru Fujimoto; Toshifumi Takahashi; Kei Mizuno; Masashi Kubota; Toshinari Yamasaki; Koji Yoshimura; Masahiro Tamaki; Yoshiyuki Nagumo; Hiroaki Kawanishi; Yu Miyazaki; Hiroki Oshiro; Ryoma Kurahashi; Norihiko Masuda; Yuki Makino; Go Kobori; Shusuke Akamatsu; Satoshi Morita; Takashi Kobayashi; Takayuki Goto
err分享
err收藏
Efficacy and safety of eribulin mesylate vs. docetaxel or paclitaxel, combined with trastuzumab and pertuzumab, as first-line treatment for HER2-positive locally advanced or metastatic breast cancer: updated subgroup analyses of JBCRG-M06/EMERALD甲磺酸艾瑞布林与多西他赛或紫杉醇联合曲妥珠单抗和帕妥珠单抗作为HER2阳性局部晚期或转移性乳腺癌的一线治疗的疗效和安全性：JBCRG-M06/EMERALD研究的更新亚组分析
errBreast Cancer Research and Treatment
IF3
err2026-07-08
err0
PREAI
errNorikazu Masuda; Shigehira Saji; Yasuyuki Kojima; Masahiro Kitada; Hiroshi Tada; Tsutomu Iwasa; Kei Koizumi; Tsuguo Iwatani; Yasuaki Sagara; Takashi Kuwayama; Masafumi Shimoda; Tatsunari Sasada; Koichiro Tsugawa; Yoshihiro Kawaguchi; Akihiko Shimomura; Takuhiro Yamaguchi; Hiroki Hasegawa; Shun Osaka; Satoshi Morita; Toshinari Yamashita
err分享
err收藏
Quality-of-life assessment in the randomized JBCRG-M06/EMERALD study of eribulin plus dual HER2 blockade in HER2-positive locally advanced or metastatic breast cancer在JBCRG-M06/EMERALD研究中评估厄洛替尼联合双重HER2阻断在HER2阳性局部晚期或转移性乳腺癌中的生活质量评估
errBreast Cancer
IF2.9
err2026-06-10
err0
PREAI
errTsuguo Iwatani; Norikazu Masuda; Shigehira Saji; Takuhiro Yamaguchi; Yasuyuki Kojima; Masahiro Kitada; Hiroshi Tada; Tsutomu Iwasa; Kei Koizumi; Hideo Shigematsu; Yasuaki Sagara; Toshitaka Okuno; Yoshie Hasegawa; Eriko Tokunaga; Tadahiko Shien; Uhi Toh; Hiroki Hasegawa; Shun Osaka; Satoshi Morita; Toshinari Yamashita
err分享
err收藏
Association between serum lactate dehydrogenase level and renal outcome in patients with advanced chronic kidney disease without diabetes mellitus血清乳酸脱氢酶水平与无糖尿病的晚期慢性肾脏病患者肾功能结局的关系
errClinical and Experimental Nephrology
IF1.7
err2026-06-01
err0
PREAI
errNakamura, Yoshihiro; Kurasawa, Shimon; Imaizumi, Takahiro; Hayashi, Terumasa; Narita, Ichiei; Tanabe, Kenichiro; Morita, Satoshi; Tsubakihara, Yoshiharu; Imai, Enyu; Akizawa, Tadao; Maruyama, Shoichi
err分享
err收藏
Health-related quality of life with pertuzumab retreatment: Secondary analysis of the PRECIOUS trial接受帕妥珠单抗再治疗患者的生活质量：PRECIOUS试验的二次分析
errBreast
IF7.9
err2026-05-23
err0
errOAAI
errTaira, Naruto; Yamamoto, Yutaka; Iwata, Hiroji; Saji, Shigehira; Takahashi, Masato; Yoshinami, Tetsuhiro; Ueno, Takayuki; Toyama, Tatsuya; Takano, Toshimi; Kashiwaba, Masahiro; Tsugawa, Koichiro; Tada, Hiroshi; Hara, Fumikata; Fujisawa, Tomomi; Niikura, Naoki; Morita, Satoshi; Masuda, Norikazu
err分享
err收藏
Nanofiber-based platform for quantitative analysis of human oligodendrocyte ensheathment with pharmacological perturbations基于纳米纤维平台的药理学扰动下人少突胶质细胞包裹的定量分析
errStem Cell Reports
IF5.1
err2026-05-14
err0
errOAAI
errSatoshi Morita; Takayuki Kondo; Keiko Imamura; Yukako Sagara; Kayoko Tsukita; Hisanori Tokuda; Yoshihisa Kaneda; Takayuki Izumo; Yoshihiro Nakao; Haruhisa Inoue
err分享
err收藏
Reduced-fluence photodynamic therapy versus placebo for central serous chorioretinopathy (REPLAY trial): rationale and study protocol of a pivotal double-blind randomised controlled trial低能量光动力疗法与安慰剂治疗中心性浆液性脉络膜视网膜病变（REPLAY试验）：一项关键性双盲随机对照试验的方案和原理
errBMJ Open
IF2.3
err2026-04-21
err0
PREAI
errMiyake, Masahiro; Takahashi, Ayako; Baba, Takayuki; Maruko, Ichiro; Ohnaka, Masayuki; Kuroda, Akiko; Tada, Harue; Hidaka, Yu; Ibi, Yumiko; Muraoka, Yuki; Ito, Tatsuya; Morita, Satoshi; Sakamoto, Taiji; Imai, Hisanori; Yamamoto, Shuichi; Iida, Tomohiro; Tsujikawa, Akitaka
err分享
err收藏
A novel quantitative method for CT assessment of bronchiectasis using AI-based airway segmentation and upper limits of normal airway caliber一种基于AI气道分割和气道直径正常上限的支气管扩张CT定量评估新方法
errRespiratory Research
IF5
err2026-03-16
err0
errOAAI
errNaoya Tanabe; Atsuyasu Sato; Tomoki Maetani; Ryo Sakamoto; Motonari Fukui; Izuru Masuda; Megumi Kanasaki; Tomohiro Handa; Susumu Sato; Satoshi Morita; Toyohiro Hirai
err分享
err收藏
Risk Stratification Based on Imaging Findings for Pregnancies With Subamniotic or Subchorionic Hematoma on Placental MRI根据胎盘MRI羊膜下或绒毛膜下血肿的影像学表现进行风险分层
errJOURNAL OF MAGNETIC RESONANCE IMAGING
IF3.5
err2026-01-01
err0
PREAI
errHarada, Kumi; Himoto, Yuki; Chigusa, Yoshitsugu; Tomotaki, Seiichi; Kurata, Yasuhisa; Yoshida, Atsushi; Muramatsu, Yuriko; Hidaka, Yu; Morita, Satoshi; Matsumoto, Yuka Kuriyama; Kido, Aki; Kirita, Mitsuhiro; Minamiguchi, Sachiko; Mandai, Masaki; Nakamoto, Yuji
err分享
err收藏
Real-world multicenter study of immune checkpoint inhibitors in advanced cervical cancer across HPV-associated and HPV-independent subtypes真实世界中免疫检查点抑制剂在HPV相关和HPV非相关亚型晚期宫颈癌中的多中心研究
errInternational Journal of Clinical Oncology
IF2.8
err2025-11-26
err0
PREAI
errKazuhiro Ko; Mayu Fukuda; Koji Yamanoi; Nobutaka Hayashi; Hisateru Yasui; Takuma Hayashi; Yoshihiro Yakushijin; Takehiko Tsumura; Atsushi Shirakawa; Chiho Nakashima; Yoshinori Imamura; Chikako Yamauchi; Toshio Shimizu; Takahito Ashihara; Nobuhiro Shibata; Takeshi Kotake; Aya Toyofuku; Taito Miyamoto; Rin Mizuno; Mana Taki; Ryusuke Murakami; Satoshi Morita; Manabu Muto; Masaki Mandai
err分享
err收藏
Gene-scale in vitro reconstitution reveals histone acetylation directly controls chromatin architecture基因尺度的体外重组实验表明，组蛋白乙酰化直接调控染色质结构。
errScience Advances
IF12.5
err2025-11-19
err0
PREAI
errYohsuke T. Fukai; Tomoya Kujirai; Masatoshi Wakamori; Setsuko Kanamura; Lisa Yamauchi; Somayeh Zeraati; Satoshi Morita; Chiharu Tanegashima; Mitsutaka Kadota; Mikako Shirouzu; Hitoshi Kurumizaka; Takashi Umehara; Kyogo Kawaguchi
err分享
err收藏
Lung immune prognostic index as a biomarker for predicting the benefit of immune checkpoint inhibitor plus chemotherapy in older patients with non-small cell lung cancer: a secondary analysis of the NEJ057 study肺癌免疫预后指数作为预测免疫检查点抑制剂联合化疗在非小细胞肺癌老年患者中获益的生物标志物：NEJ057研究的二次分析
errInternational Journal of Clinical Oncology
IF2.8
err2025-11-05
err0
PREAI
errTakehiro Tozuka; Yoko Tsukita; Kohei Kushiro; Shinobu Hosokawa; Hitomi Nogawa; Satoshi Arai; Sayo Soda; Daisuke Arai; Kei Takamura; Ryoichi Honda; Kosuke Hamai; Yukiko Namba; Yasutaka Kawai; Takashi Kikuchi; Kensuke Nakazawa; Takayuki Honda; Noriyuki Ebi; Yutaka Yamada; Tomonori Makiguchi; Masahiro Seike; Satoshi Morita; Kunihiko Kobayashi; Hajime Asahina
err分享
err收藏
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2024 for the treatment of colorectal cancerKinugasa, Y.; Uehara, K.; Yamaguchi, K.; Saito, Y.; Murofushi, K.; Sugai, T.; Ishiguro, M.; Ishihara, S.; Ueno, H.; Oka, S.; 等. 日本结直肠癌协会（JSCCR）. 日本结直肠癌协会2024年结直肠癌治疗指南. 国际临床肿瘤学杂志, 2025, 30, 2410–2463. [Google Scholar] [CrossRef]
errINTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
IF2.8
err2025-11-01
err1
PREAI
errKinugasa, Yusuke; Uehara, Kay; Yamaguchi, Kensei; Saito, Yutaka; Murofushi, Keiko; Sugai, Tamotsu; Ishiguro, Megumi; Ishihara, Soichiro; Ueno, Hideki; Oka, Shiro; Kato, Takeshi; Kanemitsu, Yukihide; Kawakami, Hisato; Kobayashi, Hirotoshi; Sakamoto, Yoshihiro; Shiozawa, Manabu; Shiomi, Akio; Shinozaki, Eiji; Takiyama, Hirotoshi; Taniguchi, Hiroya; Nakajima, Takako Eguchi; Hotta, Kinichi; Matsuda, Keiji; Murata, Kohei; Morita, Satoshi; Yamazaki, Kentaro; Yoshida, Masahiro; Yamaguchi, Naohiko; Kagawa, Hiroyasu; Yamauchi, Shinichi; Ajioka, Yoichi
err分享
err收藏
Age-Related Associations of Blood Pressure and Arterial Stiffness with Retinal Arterial Structure年龄与血压、动脉僵硬度及视网膜动脉结构的相关性研究
errOphthalmology Science
IF4.6
err2025-10-02
err0
errOAAI
errRan Xiang; Yuki Muraoka; Takahiro Kogo; Yu Hidaka; Yuki Mori; Masayuki Hata; Masahiro Miyake; Satoshi Morita; Yasuharu Tabara; Fumihiko Matsuda; Akitaka Tsujikawa
err分享
err收藏
Neutrophils predominate as IL1B-expressing cells in Schnitzler syndrome: Insights from the SCan study to evaluate the efficacy and safety of canakinumab in Japanese patients中性粒细胞作为IL1B表达细胞在施尼茨综合征中占主导地位：来自SCan研究对日本患者中卡那奴单抗疗效和安全性的评估见解
errALLERGOLOGY INTERNATIONAL
IF6.7
err2025-10-01
err2
errOAAI
errKambe, Naotomo; Inoue, Norimitsu; Ueki, Yoko; Zhou, Yuyi; Yonekura, Satoru; Katsuo, Kosuke; Nakamizo, Satoshi; Tsujimoto, Hiroshi; Ohtani, Katsuki; Yoshifuji, Hajime; Jo, Tomoyasu; Izawa, Kazushi; Yamamoto, Mayuko; Takemura, Koji; Kagami, Shin-ichiro; Kawahara, Yoshie; Amino, Yoko; Ibi, Yumiko; Morita, Satoshi; Kanazawa, Nobuo
err分享
err收藏
Durvalumab, carboplatin, and etoposide in patients who are treatment-naive with extensive-stage small-cell lung cancer and poor performance status (NEJ045A): a single-arm phase 2 trial度鲁妥单抗、卡铂和依托泊苷用于治疗初治广泛期小细胞肺癌且体力状况较差的患者（NEJ045A）：一项单臂Ⅱ期试验
errThe Lancet Respiratory Medicine
IF32.8
err2025-09-28
err0
PREAI
errTetsuhiko Asao; Yu Saida; Satoshi Watanabe; Akira Kisohara; Kazuma Kishi; Ryo Morita; Taku Nakagawa; Yoko Tsukita; Naoki Furuya; Taichi Miyawaki; Nobuhisa Ishikawa; Tadaaki Yamada; Takahiro Tanaka; Satoshi Morita; Toshiaki Kikuchi; Makoto Maemondo; Kunihiko Kobayashi
err分享
err收藏
A Phase 2 study of osimertinib in combination with platinum-pemetrexed in patients with uncommon epidermal growth factor receptor-mutated advanced non-small cell lung cancer (NEJ067/OPAL2)一项奥希替尼联合铂类-培美曲塞治疗 uncommon epidermal growth factor receptor-mutated advanced non-small cell lung cancer（NEJ067/OPAL2）的II期研究
errClinical Lung Cancer
IF3.3
err2025-08-26
err0
PREAI
errDaisuke Morinaga; Megumi Furuta; Satoshi Morita; Eisaku Miyauchi; Kunihiko Kobayashi; Makoto Maemondo; Hajime Asahina
err分享
err收藏
Durvalumab plus irinotecan + cisplatin for untreated extensive-stage small cell lung cancer: REBORN, phase II study (WJOG13520L)度伐利尤单抗联合伊立替康+顺铂用于未经治疗的广泛期小细胞肺癌：REBORN，II期研究（WJOG13520L）
errLung Cancer
IF4.4
err2025-06-29
err0
errOAAI
errMotoko Tachihara; Hiroyasu Shoda; Yuki Akazawa; Takayo Ota; Masahide Oki; Yuki Sato; Shunichi Sugawara; Satoshi Ikeda; Toshihide Yokoyama; Hiroyasu Kaneda; Shoichi Itoh; Akihiro Bessho; Nobuyuki Katakami; Satoshi Morita; Kazuhiko Nakagawa; Isamu Okamoto; Nobuyuki Yamamoto
err分享
err收藏
Validation of the predictive ability for recurrence and the clinical utility of the 95-gene classifier (95GC) through an integrated analysis of five studies通过五项研究的综合分析验证95-gene classifier（95GC）对复发的预测能力及其临床应用价值
errBreast Cancer
IF2.9
err2025-06-25
err0
PREAI
errAya Imai; Ryo Tsunashima; Yu Hidaka; Sae Kitano; Chikage Kato; Akira Watanabe; Midori Morita; Koichi Sakaguchi; Yoshiaki Sota; Masahiko Suzuki; Takayuki Kinoshita; Seiichi Imanishi; Masahiro Oikawa; Yoshihiko Kamada; Ken-ichi Ito; Takaaki Oba; Shin Takayama; Fumine Tsukamoto; Mina Takahashi; Yutaka Hatanaka; Naoto T. Ueno; Kenzo Shimazu; Satoshi Morita; Yasuto Naoi
err分享
err收藏

研究方向

暂无研究方向
合作学者
合作期刊
M
Masatoshi Kudo
H 指数: 143 · 论文数: 2.8K
T
Tony Mok
H 指数: 131 · 论文数: 1.1K
O
Osamu Takeuchi
H 指数: 119 · 论文数: 500
Y
Yukio Ando
H 指数: 119 · 论文数: 5.1K
Y
Yasushi Yatabe
H 指数: 116 · 论文数: 1.2K
查看更多